Phosphatidylinositol 4-kinase is a viable target for the radical cure of Babesia microti infection in immunocompromised hosts

Phosphatidylinositol 4-kinase is a viable target for the radical cure of Babesia microti infection in immunocompromised hosts

Human babesiosis is a global emerging tick-borne disease caused by infection with intra-erythrocytic parasites of the genus Babesia. With the rise in human babesiosis cases, the discovery and development of new anti-Babesia drugs are essential. Phosphatidylinositol 4-kinase (PI4K) is a widely presen...

Full description

Bibliographic Details
Main Authors: Shengwei Ji, Eloiza May Galon, Moaz M. Amer, Iqra Zafar, Masashi Yanagawa, Masahito Asada, Jinlin Zhou, Mingming Liu, Xuenan Xuan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Babesia microti
babesiosis
phosphatidylinositol 4-kinase
treatment
MMV390048
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2022.1048962/full

Similar Items

Similar Items